Vertex Pharmaceuticals has been attracting investor attention due to strong recent stock performance. The company's shares ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Goldman Sachs said it reiterated Buy ratings on OneStream ( NASDAQ: OS ), Vertex ( NASDAQ: VERX) and Workiva ( NYSE: WK) ...
17h
Zacks.com on MSNVertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should KnowVertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Vertex Pharmaceuticals VRTX has outperformed the market over the past 15 years by 5.86% on an annualized basis producing an average annual return of 17.7%. Currently, Vertex Pharmaceuticals has a ...
1d
Zacks.com on MSNVertex to Report Q4 Earnings: What's in Store for the Stock?Vertex, Inc. VERX is scheduled to report fourth-quarter 2024 results before market open on Feb. 27. Find the latest EPS ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has approved JOURNAVX™ (suzetrigine), an oral, non-opioid, highly selective ...
On its pricing page, the tech giant has now detailed what it will charge its Vertex AI users to access its video generation ...
Read about a $100 million single-award IDIQ contract awarded by the FBI to Vertex Aerospace for aviation maintenance support ...
Florida Tech's partnerships strengthen and grow our businesses, our economy and our communities across the Space Coast.
Non-opioid pain therapies are entering an unprecedented era, marked by the landmark FDA approval of Vertex’s Journavx and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results